olaparib placebo

Phase 3

AstraZeneca

olaparib placebo is one of 8 therapeutic programs targeting Endometrial Neoplasms. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Endometrial NeoplasmsActive, not recruiting

Endometrial NeoplasmsPhase 3

Active, not recruiting

Competition

Competitive Landscape

7 competitors in Endometrial Neoplasms

#DrugCompanyPhaseTrials

Taxol

Teva

Phase 3

3 2

Lynparza

AstraZeneca

Phase 3

1 3

Imfinzi

AstraZeneca

Phase 3

1 4

Paraplatin

AAvyxa

Phase 3

2 5

Alli

EEngelhard Arzneimittel GmbH & Co.KG

Phase 2

1 6

olaparib placebo

AstraZeneca

Phase 3

1 7

Progestin

WWashington University School of Medicine

Phase 2

1 8

Gnrh Ant

Merck & Co.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q2 2027

Phase 3Active, not recruiting

Endometrial Neoplasms

NCT04269200

Clinical

Trials by Indication[1]

Endometrial Neoplasms1 trial

A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination With Durvalumab, Followed by Maintenance Durvalumab With or Without Olaparib in Patients With Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)

Active, not recruiting· AstraZeneca logo

AstraZeneca·Phase 3·NCT04269200·805 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for olaparib placebo. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for olaparib placebo. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — AstraZeneca company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 3[1]
Company: AstraZeneca

olaparib placebo

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q2 2027

Trials by Indication[1]

Endometrial Neoplasms1 trial

References

Drug Info

Quick Facts

Related News